ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma

Li, Xiangpan; Xiong, Kewei*; Bi, Dong; Zhao, Chen*武汉大学
Frontiers in Genetics2022-4-25DOI: 10.3389/fgene.2022.839884
1被引4阅读
引用收藏
分享

摘要

Glioma is a malignancy with the highest mortality in central nervous system disorders. Here, we implemented the computational tools based on CRISPR/Cas9 to predict the clinical outcomes and biological characteristics of low-grade glioma (LGG). The transcriptional expression profiles and clinical phenotypes of LGG patients were retrieved from The Cancer Genome Atlas and Chinese Glioma Genome Atlas. The CERES algorithm was used to screen for LGG-lethal genes. Cox regression and random survival forest were adopted for survival-related gene selection. Nonnegative matrix factorization distinguished patients into different clusters. Single-sample gene set enrichment analysis was employed to create a novel CRISPR/Cas9 screening potential index (CCSPI), and patients were stratified into low- and high-CCSPI groups. Survival analysis, area under the curve values (AUCs), nomogram, and tumor microenvironment exploration were included for the model validation. A total of 20 essential genes in LGG were used to classify patients into two clusters and construct the CCSPI system. High-CCSPI patients were associated with a worse prognosis of both training and validation set (p < 0.0001) and higher immune fractions than low-CCSPI individuals. The CCSPI system had a promising performance with 1-, 3-, and 5-year AUCs of 0.816, 0.779, 0.724, respectively, and the C-index of the nomogram model reached 0.743 (95% CI = 0.725-0.760). Immune-infiltrating cells and immune checkpoints such as PD-1/PD-L1 and POLD3 were positively associated with CCSPI. In conclusion, the CCSPI had prognostic value in LGG, and the model will deepen our cognition of the interaction between the CNS and immune system in different LGG subtypes.

学科与关键词

关键词
CRISPRCas9CNS-central nervous systemtumor microenvironmentmachine learninglow-grade glioma
相关
加载中…
  • CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment
    Wang, Fang; Tao, Zhennan; Tian, Zhen; Jin, Jiaqi; Dong, Jiawei; Dai, Yuxiang; Yu, Wanli*; Tang, Bin*; Hu, Shaoshan*Frontiers in Genetics, 2022, 13: 874896.被引 2
  • Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas
    Huang, Hao; Lv, Zhonghua; Yang, Longkun; Zhang, Xing; Deng, Ying; Huang, Zhicong; Bi, Haoran; Sun, Xizhuo; Zhang, Ming; Hu, Dongsheng; Liang, Hongsheng*; Hu, Fulan*Journal of Cancer Research and Clinical Oncology, 2023, 149(13): 11499-11515.
  • A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
    Yan, Xiuwei; Wang, Nan; Dong, Jiawei; Wang, Fang; Zhang, Jiheng; Hu, Xueyan; Zhao, Hongtao; Gao, Xin; Liu, Zhihui*; Li, Yongzhe*; Hu, Shaoshan*Frontiers in Molecular Biosciences, 2022, 9: 966843.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-04-25
卷期
第 13 卷
页码
839884
DOI
10.3389/fgene.2022.839884
期刊等级
3区
成果收录
SCIE

作者

  • L

    Li, Xiangpan (第一作者)

    wuhan univ

  • X

    Xiong, Kewei (通讯)

    wuhan univ · cent china normal univ

查看全部 4 位作者收起作者
  • B

    Bi, Dong

    wuhan univ

  • Z

    Zhao, Chen (通讯)

    wuhan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417